MAZZONE, MASSIMILIANO
 Distribuzione geografica
Continente #
AS - Asia 2.738
NA - Nord America 2.040
SA - Sud America 519
EU - Europa 291
AF - Africa 53
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 5.645
Nazione #
US - Stati Uniti d'America 1.957
SG - Singapore 1.747
BR - Brasile 437
CN - Cina 404
VN - Vietnam 262
HK - Hong Kong 103
IT - Italia 56
CA - Canada 43
GB - Regno Unito 43
IN - India 35
DE - Germania 33
BD - Bangladesh 32
ES - Italia 30
AR - Argentina 23
FR - Francia 21
IQ - Iraq 21
MX - Messico 21
EC - Ecuador 20
JP - Giappone 20
TR - Turchia 18
ZA - Sudafrica 18
PL - Polonia 17
RU - Federazione Russa 16
PK - Pakistan 14
UA - Ucraina 13
UZ - Uzbekistan 13
NL - Olanda 12
ID - Indonesia 11
PY - Paraguay 11
AT - Austria 10
KE - Kenya 8
IE - Irlanda 7
SE - Svezia 7
VE - Venezuela 7
AE - Emirati Arabi Uniti 6
CL - Cile 6
CO - Colombia 6
CZ - Repubblica Ceca 6
EG - Egitto 6
JO - Giordania 5
PE - Perù 5
PH - Filippine 5
SA - Arabia Saudita 5
TN - Tunisia 5
TT - Trinidad e Tobago 5
LT - Lituania 4
MA - Marocco 4
PS - Palestinian Territory 4
UY - Uruguay 4
AZ - Azerbaigian 3
DO - Repubblica Dominicana 3
DZ - Algeria 3
FI - Finlandia 3
HN - Honduras 3
IL - Israele 3
MN - Mongolia 3
MY - Malesia 3
AU - Australia 2
BG - Bulgaria 2
CH - Svizzera 2
CR - Costa Rica 2
ET - Etiopia 2
GA - Gabon 2
HU - Ungheria 2
IR - Iran 2
JM - Giamaica 2
KH - Cambogia 2
KZ - Kazakistan 2
LB - Libano 2
NG - Nigeria 2
NP - Nepal 2
OM - Oman 2
PT - Portogallo 2
AL - Albania 1
AM - Armenia 1
BB - Barbados 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CM - Camerun 1
DK - Danimarca 1
GE - Georgia 1
GP - Guadalupe 1
GT - Guatemala 1
KG - Kirghizistan 1
KR - Corea 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
MD - Moldavia 1
MZ - Mozambico 1
NR - Nauru 1
PR - Porto Rico 1
QA - Qatar 1
SK - Slovacchia (Repubblica Slovacca) 1
SY - Repubblica araba siriana 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 5.645
Città #
Singapore 720
San Jose 396
Ashburn 389
The Dalles 311
Shanghai 171
Dallas 163
Beijing 148
Hong Kong 97
Ho Chi Minh City 96
Hanoi 62
Los Angeles 48
New York 39
São Paulo 37
Seattle 31
Boardman 30
Santa Clara 27
Assago 20
Montreal 20
Chandler 18
Da Nang 17
Warsaw 17
Rio de Janeiro 16
Orem 15
Tokyo 15
Wilmington 14
Chicago 12
Denver 12
Tashkent 12
Belo Horizonte 11
Council Bluffs 11
Milan 11
Amsterdam 10
Curitiba 10
Hải Dương 10
Johannesburg 10
Murcia 10
Atlanta 9
Brooklyn 9
Haiphong 9
London 9
Boston 8
Brasília 8
Chennai 8
Manchester 8
Porto Alegre 8
Abbiategrasso 7
Ankara 7
Dublin 7
Munich 7
San Mateo 7
São José dos Campos 7
Basra 6
Buffalo 6
Dhaka 6
Guayaquil 6
Istanbul 6
Nairobi 6
Paris 6
Stockholm 6
Vienna 6
Amman 5
Arapiraca 5
Baghdad 5
Biên Hòa 5
Cape Town 5
Houston 5
Joinville 5
Lima 5
Mexico City 5
Mumbai 5
Quito 5
Reston 5
Asunción 4
Belém 4
Bến Tre 4
Cairo 4
Columbus 4
Cuenca 4
Erbil 4
Fortaleza 4
Goiânia 4
Islamabad 4
Jacobina 4
Lahore 4
Montevideo 4
Naples 4
Phủ Lý 4
Poplar 4
San Francisco 4
Secaucus 4
Woodbridge 4
Baku 3
Brno 3
Calgary 3
Caçador 3
Chapecó 3
Charlotte 3
Concórdia 3
Florianópolis 3
Frankfurt am Main 3
Totale 3.371
Nome #
Activation of the VEGFC/VEGFR3 Pathway Induces Tumor Immune Escape in Colorectal Cancer 149
Monocyte biomarkers for cancer detection 105
PHD2 inhibition for blood vessel normalization, and uses thereof 93
Nicotinamide phosphoribosyltransferase acts as a metabolic gate for mobilization of myeloid-derived suppressor cells 81
"Active" cancer immunotherapy by anti-Met antibody gene transfer 72
Modulating transendothelial migration and recruitment of granulocytes by modulating c-Met pathway 63
Functional MMP-10 is required for efficient tissue repair after experimental hind limb ischemia 57
An Integrated Gene Expression Landscape Profiling Approach to Identify Lung Tumor Endothelial Cell Heterogeneity and Angiogenic Candidates 55
Anti-PlGF Inhibits Growth of VEGF(R)-Inhibitor-Resistant Tumors without Affecting Healthy Vessels 53
α-ketoglutarate orchestrates macrophage activation through metabolic and epigenetic reprogramming 53
Endothelial deficiency of L1 reduces tumor angiogenesis and promotes vessel normalization 52
Tumor-associated macrophages: a short compendium 52
The PP2A B55a subunit as novel PHD2 interacting protein and implications for cancer 51
Building in resistance to endothelial cell death 49
FXR agonist obeticholic acid reduces hepatic inflammation and fibrosis in a rat model of toxic cirrhosis 49
An uncleavable form of pro-scatter factor suppresses tumor growth and dissemination in mice 49
Induction/monitoring of arteriogenesis using SDF1 and PDGFB or inhibition of PHD2 48
Blood Vessel Proximity Shapes Cancer Cell Metabolism 48
BNIP3 promotes HIF-1α-driven melanoma growth by curbing intracellular iron homeostasis 48
Protein Phosphatase 2A Mediates YAP Activation in Endothelial Cells Upon VEGF Stimulation and Matrix Stiffness 47
Anti-placental growth factor reduces bone metastasis by blocking tumor cell engraftment and osteoclast differentiation 47
Branching morphogenesis and antiangiogenesis candidates: Tip cells lead the way 47
Macrophage skewing by Phd2 haplodeficiency prevents ischaemia by inducing arteriogenesis 46
MIF-Mediated Hemodilution Promotes Pathogenic Anemia in Experimental African Trypanosomosis 46
Targeting the bicarbonate transporter SLC4A4 overcomes immunosuppression and immunotherapy resistance in pancreatic cancer 46
An HGF-MSP chimera disassociates the trophic properties of scatter factors from their pro-invasive activity 46
Deficiency of the oxygen sensor prolyl hydroxylase 1 attenuates hypercholesterolaemia, atherosclerosis, and hyperglycaemia 45
Ab-induced ectodomain shedding mediates hepatocyte growth factor receptor down-regulation and hampers biological activity 45
Metron factor-1 prevents liver injury without promoting tumor growth and metastasis 45
Overcoming Resistance to Antiangiogenic Therapies 44
FLT1 and its ligands VEGFB and PlGF: Drug targets for anti-angiogenic therapy? 44
Plexin-A4 Mediates Cytotoxic T-cell Trafficking and Exclusion in Cancer 44
Dynamic stroma reorganization drives blood vessel dysmorphia during glioma growth 44
Heterozygous deficiency of PHD2 restores tumor oxygenation and inhibits metastasis via endothelial normalization 44
SLC25A26 overexpression impairs cell function via mtDNA hypermethylation and rewiring of methyl metabolism 44
Reprogramming of Amino Acid Transporters to Support Aspartate and Glutamate Dependency Sustains Endocrine Resistance in Breast Cancer 44
YAP/TAZ Orchestrate VEGF Signaling during Developmental Angiogenesis 43
Genetic targeting of the kinase activity of the Met receptor in cancer cells 43
Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene 43
Caspase-8 modulates physiological and pathological angiogenesis during retina development 43
Brain Endothelial Cells Control Fertility through Ovarian-Steroid-Dependent Release of Semaphorin 3A 43
Blockade of Glutamine Synthetase Enhances Inflammatory Response in Microglial Cells 43
Leptin brain entry via a tanycytic LepR–EGFR shuttle controls lipid metabolism and pancreas function 42
Silencing or Fueling Metastasis with VEGF Inhibitors: Antiangiogenesis Revisited 42
Antiangiogenic therapy, hypoxia, and metastasis: risky liaisons, or not? 42
B55α/PP2A limits endothelial cell apoptosis during vascular remodeling: A complementary approach to disrupt pathological vessels? 42
An HGF-MSP chimera disassociates the trophic properties of scatter factors from their pro-invasive activity 42
The Met pathway: master switch and drug target in cancer progression 41
Loss of Caveolin-1 in Metastasis-Associated Macrophages Drives Lung Metastatic Growth through Increased Angiogenesis 41
Macrophage-derived glutamine boosts satellite cells and muscle regeneration 41
Tanycytic VEGF-A boosts blood-hypothalamus barrier plasticity and access of metabolic signals to the arcuate nucleus in response to fasting 40
Prognostic impact of a compartment-specific angiogenic marker profile in patients with pancreatic cancer 40
PHD1 regulates p53-mediated colorectal cancer chemoresistance 40
Regulation of Blood and Lymphatic Vessels by Immune Cells in Tumors and Metastasis 40
A collaborative synthetase 40
Loss or Silencing of the PHD1 Prolyl Hydroxylase Protects Livers of Mice Against Ischemia/Reperfusion Injury 40
Tumour growth inhibition and anti-metastatic activity of a mutated furin-resistant Semaphorin 3E isoform 40
Preclinical and clinical evaluation of MET functions in cancer cells and in the tumor stroma 39
The anti-proliferative effect of L-carnosine correlates with a decreased expression of hypoxia inducible factor 1 alpha in human colon cancer cells 39
MicroRNA-Mediated Metabolic Shaping of the Tumor Microenvironment 38
ESDN inhibits melanoma progression by blocking E-selectin expression in endothelial cells via STAT3 37
Genetic Deficiency in Plasma Protein HRG Enhances Tumor Growth and Metastasis by Exacerbating Immune Escape and Vessel Abnormalization 37
Inhibition of tumor angiogenesis and growth by a small-molecule multi-FGF receptor blocker with allosteric properties 37
IL1b promotes immune suppression in the tumor microenvironment independent of the inflammasome and gasdermin D 37
Systemic and Targeted Delivery of Semaphorin 3A Inhibits Tumor Angiogenesis and Progression in Mouse Tumor Models 37
Betulinic Acid Hydroxamate is Neuroprotective and Induces Protein Phosphatase 2A-Dependent HIF-1α Stabilization and Post-transcriptional Dephosphorylation of Prolyl Hydrolase 2 37
Quiescent Endothelial Cells Upregulate Fatty Acid β-Oxidation for Vasculoprotection via Redox Homeostasis 37
MiR-511-3p Modulates Genetic Programs of Tumor-Associated Macrophages 36
Role of delta-like-4/notch in the formation and wiring of the lymphatic network in zebrafish 36
Loss of the oxygen sensor PHD3 enhances the innate immune response to abdominal sepsis 36
Tumor vessel co-option probed by single-cell analysis 36
Iron supplementation is sufficient to rescue skeletal muscle mass and function in cancer cachexia 36
Growing tumor vessels: More than one way to skin a cat - Implications for angiogenesis targeted cancer therapies 36
Tumor hypoxia does not drive differentiation of tumor-associated macrophages but rather fine-tunes the M2-like macrophage population 36
Pharmacologic or Genetic Targeting of Glutamine Synthetase Skews Macrophages toward an M1-like Phenotype and Inhibits Tumor Metastasis 36
Tumor matrix stiffness promotes metastatic cancer cell interaction with the endothelium 36
Targeting the tumor and its microenvironment by a dual-function decoy Met receptor 36
Factor-inhibiting HIF-1 (FIH-1) is required for human vascular endothelial cell survival 36
Metabolic traits ruling the specificity of the immune response in different cancer types 36
Targeting the tumor and its microenvironment by a dual-function decoy Met receptor 35
Gene-Targeting of Phd2 Improves Tumor Response to Chemotherapy and Prevents Side-Toxicity 35
Deficiency or inhibition of oxygen sensor Phd1 induces hypoxia tolerance by reprogramming basal metabolism 35
Copy number load predicts outcome of metastatic colorectal cancer patients receiving bevacizumab combination therapy 35
Hypoxic cancer-associated fibroblasts increase NCBP2-AS2/HIAR to promote endothelial sprouting through enhanced VEGF signaling 35
Hypoxia determines survival outcomes of bacterial infection through HIF-1α–dependent reprogramming of leukocyte metabolism 35
Drug discovery: A lifeline for suffocating tissues 35
The Fragile X Protein binds mRNAs involved in cancer progression and modulates metastasis formation 34
PHD2 Targeting Overcomes Breast Cancer Cell Death upon Glucose Starvation in a PP2A/B55α-Mediated Manner 34
Secreted CLIC3 drives cancer progression through its glutathione-dependent oxidoreductase activity 34
Pro-tumorigenic functions of macrophages at the primary, invasive and metastatic tumor site 34
The c-MET receptor tyrosine kinase contributes to neutrophil-driven pathology in cutaneous leishmaniasis 34
Neutrophils enhance early Trypanosoma brucei infection onset 34
Regulation of Angiogenesis by Oxygen and Metabolism 34
Semaphorin7A regulates neuroglial plasticity in the adult hypothalamic median eminence 33
Inhibition of prolyl hydroxylase domain proteins selectively enhances venous thrombus neovascularisation 33
Targeting neuropilin-1 with nanobodies reduces colorectal carcinoma development 33
The impact of hypoxia on tumor-associated macrophages 33
HRG inhibits tumor growth and metastasis by inducing macrophage polarization and vessel normalization through downregulation of PlGF 33
Stroma-derived miR-214 coordinates tumor dissemination 33
The tumour microenvironment harbours ontogenically distinct dendritic cell populations with opposing effects on tumour immunity 33
Totale 4.387
Categoria #
all - tutte 33.250
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 33.250


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20216 0 0 0 0 0 0 0 0 0 2 0 4
2021/202218 0 0 0 3 0 0 0 2 0 2 6 5
2022/202345 5 2 3 7 2 4 0 5 11 3 3 0
2023/2024529 0 3 3 3 2 4 2 1 146 27 145 193
2024/20251.454 45 5 4 14 11 118 83 92 301 392 184 205
2025/20263.729 638 357 245 295 141 242 1.233 187 217 174 0 0
Totale 5.801